Knowledge gaps in cardiovascular care of the older adult population: a scientific statement from the American Heart Association, American College of Cardiology, and …

MW Rich, DA Chyun, AH Skolnick, KP Alexander… - Circulation, 2016 - Am Heart Assoc
The incidence and prevalence of most cardiovascular disorders increase with age, and
cardiovascular disease is the leading cause of death and major disability in adults≥ 75 …

ADHD drugs and serious cardiovascular events in children and young adults

WO Cooper, LA Habel, CM Sox, KA Chan… - … England Journal of …, 2011 - Mass Medical Soc
Background Adverse-event reports from North America have raised concern that the use of
drugs for attention deficit–hyperactivity disorder (ADHD) increases the risk of serious …

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial

JL Mega, E Braunwald, S Mohanavelu, P Burton… - The Lancet, 2009 - thelancet.com
Background Rivaroxaban is an oral direct factor Xa inhibitor that has been effective in
prevention of venous thromboembolism in patients undergoing elective orthopaedic surgery …

Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction

RL McNamara, Y Wang, J Herrin, JP Curtis… - Journal of the American …, 2006 - jacc.org
Objectives: We sought to determine the effect of door-to-balloon time on mortality for patients
with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous …

[HTML][HTML] Recent advances in the diagnosis and treatment of acute myocardial infarction

K Reddy, A Khaliq, RJ Henning - World journal of cardiology, 2015 - ncbi.nlm.nih.gov
Abstract The Third Universal Definition of Myocardial Infarction (MI) requires cardiac
myocyte necrosis with an increase and/or a decrease in a patient's plasma of cardiac …

The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in …

L Mandelzweig, A Battler, V Boyko… - European heart …, 2006 - academic.oup.com
Aims Our study aimed to examine the management of acute coronary syndromes (ACS) in
Europe and the Mediterranean basin, and to compare adherence to guidelines with that …

2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial …

JL Anderson, CD Adams, EM Antman, CR Bridges… - Circulation, 2011 - Am Heart Assoc
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the
Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction …

2007 focused update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American …

SB King III, SC Smith Jr, JW Hirshfeld Jr, AK Jacobs… - Circulation, 2008 - Am Heart Assoc
Interventions. Copies: This document is available on the World Wide Web sites of the
American College of Cardiology (www. acc. org), American Heart Association (my …

ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of …

LA Fleisher, JA Beckman, KA Brown, H Calkins… - Circulation, 2007 - Am Heart Assoc
It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …

Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease

CB Overgaard, V Dzavík - Circulation, 2008 - Am Heart Assoc
effects, dobutamine is a potent inotrope, with weaker chronotropic activity. Vascular smooth
muscle binding results in combined α1-adrenergic agonism and antagonism, as well as ß2 …